Status:
COMPLETED
GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin
Lead Sponsor:
Bayer
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.
Eligibility Criteria
Inclusion
- Signed written informed consent
- Age ≥ 18 years
- Diagnosed of type 2 diabetes for at least 6 months prior to enrollment
- Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months
- HbA1C≥7.5 and ≤10.0%
Exclusion
- Exclusion criteria must be read in conjunction with the local product information
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
539 Patients enrolled
Trial Details
Trial ID
NCT01248481
Start Date
September 1 2010
End Date
July 1 2012
Last Update
June 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, South Korea